Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1813 to 1823 of 1823 entries
Sorted by: Best Match Show Resources per page
Prodigal Children: Why Older Mothers Favor Their Once-Deviant Adult Children.

The journals of gerontology. Series B, Psychological sciences and social sciences

Kincaid R, Rurka M, Suitor JJ, Gillian M, Pillemer K, Mohebbi L, Mundell N, Solomon BS.
PMID: 33912909
J Gerontol B Psychol Sci Soc Sci. 2021 Apr 29; doi: 10.1093/geronb/gbab075. Epub 2021 Apr 29.

OBJECTIVES: Past research suggests that adult children who reform their deviant behaviors (i.e., problems with drugs/alcohol or the law) are more likely to become favored by their mothers, yet the reasons underlying this phenomenon are unclear. This study employs...

Cite
Kincaid R, Rurka M, Suitor JJ, et al. Prodigal Children: Why Older Mothers Favor Their Once-Deviant Adult Children. J Gerontol B Psychol Sci Soc Sci. 2021;doi: 10.1093/geronb/gbab075.
Kincaid, R., Rurka, M., Suitor, J. J., Gillian, M., Pillemer, K., Mohebbi, L., Mundell, N., & Solomon, B. S. (2021). Prodigal Children: Why Older Mothers Favor Their Once-Deviant Adult Children. The journals of gerontology. Series B, Psychological sciences and social sciences, . https://doi.org/10.1093/geronb/gbab075
Kincaid, Reilly, et al. "Prodigal Children: Why Older Mothers Favor Their Once-Deviant Adult Children." The journals of gerontology. Series B, Psychological sciences and social sciences vol. (2021). doi: https://doi.org/10.1093/geronb/gbab075
Kincaid R, Rurka M, Suitor JJ, Gillian M, Pillemer K, Mohebbi L, Mundell N, Solomon BS. Prodigal Children: Why Older Mothers Favor Their Once-Deviant Adult Children. J Gerontol B Psychol Sci Soc Sci. 2021 Apr 29; doi: 10.1093/geronb/gbab075. Epub 2021 Apr 29. PMID: 33912909.
Copy Download .nbib Format: NLM
Recall of Genomic Testing Results Among Patients with Cancer.

The oncologist

Wing SE, Hu H, Lopez L, Solomon I, Shen J, Raquel C, Sur M, Chao J, Cristea M, Fakih M, Mortimer J, Pal S, Reckamp K, Yuan Y, Gray SW.
PMID: 34355454
Oncologist. 2021 Dec;26(12):e2302-e2305. doi: 10.1002/onco.13928. Epub 2021 Aug 26.

BACKGROUND: Genomic testing of somatic and germline DNA has transformed cancer care. However, low genetic knowledge among patients may compromise care and health outcomes. Given the rise in genomic testing, we sought to understand patients' knowledge of their genetic...

Cite
Wing SE, Hu H, Lopez L, et al. Recall of Genomic Testing Results Among Patients with Cancer. Oncologist. 2021;26(12):e2302-e2305doi: 10.1002/onco.13928.
Wing, S. E., Hu, H., Lopez, L., Solomon, I., Shen, J., Raquel, C., Sur, M., Chao, J., Cristea, M., Fakih, M., Mortimer, J., Pal, S., Reckamp, K., Yuan, Y., & Gray, S. W. (2021). Recall of Genomic Testing Results Among Patients with Cancer. The oncologist, 26(12), e2302-e2305. https://doi.org/10.1002/onco.13928
Wing, Sam E, et al. "Recall of Genomic Testing Results Among Patients with Cancer." The oncologist vol. 26,12 (2021): e2302-e2305. doi: https://doi.org/10.1002/onco.13928
Wing SE, Hu H, Lopez L, Solomon I, Shen J, Raquel C, Sur M, Chao J, Cristea M, Fakih M, Mortimer J, Pal S, Reckamp K, Yuan Y, Gray SW. Recall of Genomic Testing Results Among Patients with Cancer. Oncologist. 2021 Dec;26(12):e2302-e2305. doi: 10.1002/onco.13928. Epub 2021 Aug 26. PMID: 34355454; PMCID: PMC8649013.
Copy Download .nbib Format: NLM
Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series.

Frontiers in neurology

Matos AMB, Dahy FE, de Moura JVL, Marcusso RMN, Gomes ABF, Carvalho FMM, Fernandes GBP, Felix AC, Smid J, Vidal JE, Frota NAF, Casseb J, Easton A, Solomon T, Witkin SS, Malta Romano C, de Oliveira ACP.
PMID: 34421788
Front Neurol. 2021 Aug 04;12:678924. doi: 10.3389/fneur.2021.678924. eCollection 2021.

No abstract available.

Cite
Matos AMB, Dahy FE, de Moura JVL, et al. Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series. Front Neurol. 2021;12:678924doi: 10.3389/fneur.2021.678924.
Matos, A. M. B., Dahy, F. E., de Moura, J. V. L., Marcusso, R. M. N., Gomes, A. B. F., Carvalho, F. M. M., Fernandes, G. B. P., Felix, A. C., Smid, J., Vidal, J. E., Frota, N. A. F., Casseb, J., Easton, A., Solomon, T., Witkin, S. S., Malta Romano, C., de Oliveira, A. C. P. (2021). Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series. Frontiers in neurology, 12678924. https://doi.org/10.3389/fneur.2021.678924
Matos, Aline de Moura Brasil, et al. "Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series." Frontiers in neurology vol. 12 (2021): 678924. doi: https://doi.org/10.3389/fneur.2021.678924
Matos AMB, Dahy FE, de Moura JVL, Marcusso RMN, Gomes ABF, Carvalho FMM, Fernandes GBP, Felix AC, Smid J, Vidal JE, Frota NAF, Casseb J, Easton A, Solomon T, Witkin SS, Malta Romano C, de Oliveira ACP. Subacute Cognitive Impairment in Individuals With Mild and Moderate COVID-19: A Case Series. Front Neurol. 2021 Aug 04;12:678924. doi: 10.3389/fneur.2021.678924. eCollection 2021. PMID: 34421788; PMCID: PMC8371908.
Copy Download .nbib Format: NLM
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US.

JAMA cardiology

Vaduganathan M, Claggett BL, Greene SJ, Aggarwal R, Bhatt AS, McMurray JJV, Fonarow GC, Solomon SD.
PMID: 34524394
JAMA Cardiol. 2021 Sep 15; doi: 10.1001/jamacardio.2021.3651. Epub 2021 Sep 15.

IMPORTANCE: The US Food and Drug Administration (FDA) expanded labeling for sacubitril/valsartan for use in individuals with chronic heart failure (HF) with left ventricular ejection fraction (LVEF) lower than normal. The population-level implications of implementation of sacubitril/valsartan at higher...

Cite
Vaduganathan M, Claggett BL, Greene SJ, et al. Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US. JAMA Cardiol. 2021;doi: 10.1001/jamacardio.2021.3651.
Vaduganathan, M., Claggett, B. L., Greene, S. J., Aggarwal, R., Bhatt, A. S., McMurray, J. J. V., Fonarow, G. C., & Solomon, S. D. (2021). Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US. JAMA cardiology, . https://doi.org/10.1001/jamacardio.2021.3651
Vaduganathan, Muthiah, et al. "Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US." JAMA cardiology vol. (2021). doi: https://doi.org/10.1001/jamacardio.2021.3651
Vaduganathan M, Claggett BL, Greene SJ, Aggarwal R, Bhatt AS, McMurray JJV, Fonarow GC, Solomon SD. Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US. JAMA Cardiol. 2021 Sep 15; doi: 10.1001/jamacardio.2021.3651. Epub 2021 Sep 15. PMID: 34524394; PMCID: PMC8444065.
Copy Download .nbib Format: NLM
High-Quality Primary Care Implementation: The Time is Now.

Academic pediatrics

Chung EK, Solomon BS, Perrin EM, Starmer A, Turner TL, Chandran L.
PMID: 34818589
Acad Pediatr. 2021 Nov 21; doi: 10.1016/j.acap.2021.11.011. Epub 2021 Nov 21.

No abstract available.

Cite
Chung EK, Solomon BS, Perrin EM, et al. High-Quality Primary Care Implementation: The Time is Now. Acad Pediatr. 2021;doi: 10.1016/j.acap.2021.11.011.
Chung, E. K., Solomon, B. S., Perrin, E. M., Starmer, A., Turner, T. L., & Chandran, L. (2021). High-Quality Primary Care Implementation: The Time is Now. Academic pediatrics, . https://doi.org/10.1016/j.acap.2021.11.011
Chung, Esther K, et al. "High-Quality Primary Care Implementation: The Time is Now." Academic pediatrics vol. (2021). doi: https://doi.org/10.1016/j.acap.2021.11.011
Chung EK, Solomon BS, Perrin EM, Starmer A, Turner TL, Chandran L. High-Quality Primary Care Implementation: The Time is Now. Acad Pediatr. 2021 Nov 21; doi: 10.1016/j.acap.2021.11.011. Epub 2021 Nov 21. PMID: 34818589.
Copy Download .nbib Format: NLM
Impact of Prenatal SARS-CoV-2 Infection on Infant Emergency Department Visits and Hospitalization.

Clinical pediatrics

Ungar SP, Solomon S, Stachel A, Demarco K, Roman AS, Lighter J.
PMID: 34903074
Clin Pediatr (Phila). 2021 Dec 13;99228211065898. doi: 10.1177/00099228211065898. Epub 2021 Dec 13.

To better understand the impact of prenatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on infants, this study sought to compare the risk of hospital visits and of postnatal SARS-CoV-2 infection between infants born to mothers with and...

Cite
Ungar SP, Solomon S, Stachel A, et al. Impact of Prenatal SARS-CoV-2 Infection on Infant Emergency Department Visits and Hospitalization. Clin Pediatr (Phila). 2021;99228211065898doi: 10.1177/00099228211065898.
Ungar, S. P., Solomon, S., Stachel, A., Demarco, K., Roman, A. S., & Lighter, J. (2021). Impact of Prenatal SARS-CoV-2 Infection on Infant Emergency Department Visits and Hospitalization. Clinical pediatrics, 99228211065898. https://doi.org/10.1177/00099228211065898
Ungar, Stephanie P, et al. "Impact of Prenatal SARS-CoV-2 Infection on Infant Emergency Department Visits and Hospitalization." Clinical pediatrics vol. (2021): 99228211065898. doi: https://doi.org/10.1177/00099228211065898
Ungar SP, Solomon S, Stachel A, Demarco K, Roman AS, Lighter J. Impact of Prenatal SARS-CoV-2 Infection on Infant Emergency Department Visits and Hospitalization. Clin Pediatr (Phila). 2021 Dec 13;99228211065898. doi: 10.1177/00099228211065898. Epub 2021 Dec 13. PMID: 34903074.
Copy Download .nbib Format: NLM
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF.

Circulation

Jhund PS, Solomon SD, Docherty KF, Heerspink HJL, Anand IS, Böhm M, Chopra V, de Boer RA, Desai AS, Ge J, Kitakaze M, Merkley B, O'Meara E, Shou M, Tereshchenko S, Verma S, Vinh PN, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Bengtsson O, Langkilde AM, Sjöstrand M, McMurray JJV.
PMID: 33040613
Circulation. 2021 Jan 26;143(4):298-309. doi: 10.1161/CIRCULATIONAHA.120.050391. Epub 2020 Oct 12.

BACKGROUND: Many patients with heart failure and reduced ejection fraction (HFrEF) have chronic kidney disease that complicates pharmacological management and is associated with worse outcomes. We assessed the safety and efficacy of dapagliflozin in patients with HFrEF, according to...

Cite
Jhund PS, Solomon SD, Docherty KF, et al. Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF. Circulation. 2020;143(4):298-309doi: 10.1161/CIRCULATIONAHA.120.050391.
Jhund, P. S., Solomon, S. D., Docherty, K. F., Heerspink, H. J. L., Anand, I. S., Böhm, M., Chopra, V., de Boer, R. A., Desai, A. S., Ge, J., Kitakaze, M., Merkley, B., O'Meara, E., Shou, M., Tereshchenko, S., Verma, S., Vinh, P. N., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Bengtsson, O., Langkilde, A. M., Sjöstrand, M., & McMurray, J. J. V. (2021). Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF. Circulation, 143(4), 298-309. https://doi.org/10.1161/CIRCULATIONAHA.120.050391
Jhund, Pardeep S, et al. "Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF." Circulation vol. 143,4 (2021): 298-309. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.050391
Jhund PS, Solomon SD, Docherty KF, Heerspink HJL, Anand IS, Böhm M, Chopra V, de Boer RA, Desai AS, Ge J, Kitakaze M, Merkley B, O'Meara E, Shou M, Tereshchenko S, Verma S, Vinh PN, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Bengtsson O, Langkilde AM, Sjöstrand M, McMurray JJV. Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF. Circulation. 2021 Jan 26;143(4):298-309. doi: 10.1161/CIRCULATIONAHA.120.050391. Epub 2020 Oct 12. PMID: 33040613; PMCID: PMC7834909.
Copy Download .nbib Format: NLM
Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States.

JAMA network open

Howard JM, Nandy K, Woldu SL, Margulis V.
PMID: 34106265
JAMA Netw Open. 2021 Jun 01;4(6):e2112813. doi: 10.1001/jamanetworkopen.2021.12813.

IMPORTANCE: Significant demographic disparities have been found to exist in the delivery of health care. Demographic factors associated with clinical decision-making in kidney cancer have not been thoroughly studied.OBJECTIVE: To determine whether demographic factors, including sex and race/ethnicity, are...

Cite
Howard JM, Nandy K, Woldu SL, et al. Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States. JAMA Netw Open. 2021;4(6):e2112813doi: 10.1001/jamanetworkopen.2021.12813.
Howard, J. M., Nandy, K., Woldu, S. L., & Margulis, V. (2021). Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States. JAMA network open, 4(6), e2112813. https://doi.org/10.1001/jamanetworkopen.2021.12813
Howard, Jeffrey M, et al. "Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States." JAMA network open vol. 4,6 (2021): e2112813. doi: https://doi.org/10.1001/jamanetworkopen.2021.12813
Howard JM, Nandy K, Woldu SL, Margulis V. Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States. JAMA Netw Open. 2021 Jun 01;4(6):e2112813. doi: 10.1001/jamanetworkopen.2021.12813. PMID: 34106265; PMCID: PMC8190623.
Copy Download .nbib Format: NLM
Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.

Circulation

Felker GM, Butler J, Ibrahim NE, Piña IL, Maisel A, Bapat D, Camacho A, Ward JH, Williamson KM, Solomon SD, Januzzi JL.
PMID: 34251893
Circulation. 2021 Jul 13;144(2):180-182. doi: 10.1161/CIRCULATIONAHA.121.054034. Epub 2021 Jul 12.

No abstract available.

Cite
Felker GM, Butler J, Ibrahim NE, et al. Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF. Circulation. 2021;144(2):180-182doi: 10.1161/CIRCULATIONAHA.121.054034.
Felker, G. M., Butler, J., Ibrahim, N. E., Piña, I. L., Maisel, A., Bapat, D., Camacho, A., Ward, J. H., Williamson, K. M., Solomon, S. D., Januzzi, J. L. (2021). Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF. Circulation, 144(2), 180-182. https://doi.org/10.1161/CIRCULATIONAHA.121.054034
Felker, G Michael, et al. "Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF." Circulation vol. 144,2 (2021): 180-182. doi: https://doi.org/10.1161/CIRCULATIONAHA.121.054034
Felker GM, Butler J, Ibrahim NE, Piña IL, Maisel A, Bapat D, Camacho A, Ward JH, Williamson KM, Solomon SD, Januzzi JL. Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF. Circulation. 2021 Jul 13;144(2):180-182. doi: 10.1161/CIRCULATIONAHA.121.054034. Epub 2021 Jul 12. PMID: 34251893; PMCID: PMC8270225.
Copy Download .nbib Format: NLM
Achieving Student Diversity in Dental Schools: A Model That Works.

Lacy ES, McCann AL, Miller BH, Solomon E, Reuben JS.
UIID-AD: 711
2012;76:523-533.

It is well known that there is a large disparity between the proportions of African Americans, Hispanics, and American Indians in the general U.S. population and in the nation's dental profession. While these underrepresented minorities (URMs) together make up...

Cite
Lacy ES, McCann AL, Miller BH, et al. Achieving Student Diversity in Dental Schools: A Model That Works. 2012;76:523-533
Lacy, E. S., McCann, A. L., Miller, B. H., Solomon, E., & Reuben, J. S. (2012). Achieving Student Diversity in Dental Schools: A Model That Works. 76523-533.
Lacy, E S, et al. "Achieving Student Diversity in Dental Schools: A Model That Works." vol. 76 (2012): 523-533.
Lacy ES, McCann AL, Miller BH, Solomon E, Reuben JS. Achieving Student Diversity in Dental Schools: A Model That Works. 2012;76:523-533. UIID-AD: 711.
Copy Download .nbib Format: NLM
Pediatric residents' perceptions of community involvement prior to residency.

Solomon BS, Blaschke GS, West DC, Pan RJ, Sanders L, Swigonski N, Willis E, Schwarz D.
UIID-AD: 3330
2006;6:337-41. doi: 10.1016/j.ambp.2006.08.003.

OBJECTIVES: To describe baseline perceptions of first-year pediatric residents of participating in community activities, to determine whether demographic factors are related to perceived benefits and constraints, and to identify factors associated with expected community involvement. METHODS: Pediatric residents beginning...

Cite
Solomon BS, Blaschke GS, West DC, et al. Pediatric residents' perceptions of community involvement prior to residency. 2006;6:337-41doi: 10.1016/j.ambp.2006.08.003.
Solomon, B. S., Blaschke, G. S., West, D. C., Pan, R. J., Sanders, L., Swigonski, N., Willis, E., & Schwarz, D. (2006). Pediatric residents' perceptions of community involvement prior to residency. 6337-41. https://doi.org/10.1016/j.ambp.2006.08.003
Solomon, B S, et al. "Pediatric residents' perceptions of community involvement prior to residency." vol. 6 (2006): 337-41. doi: https://doi.org/10.1016/j.ambp.2006.08.003
Solomon BS, Blaschke GS, West DC, Pan RJ, Sanders L, Swigonski N, Willis E, Schwarz D. Pediatric residents' perceptions of community involvement prior to residency. 2006;6:337-41. doi: 10.1016/j.ambp.2006.08.003. UIID-AD: 3330.
Copy Download .nbib Format: NLM
Showing 1813 to 1823 of 1823 entries